NCT02426801

Brief Summary

The purpose of this study is to assess the feasibility of using a mobile health intervention to improve adherence to asthma medication among adolescents in an urban clinic setting. The intervention consists of an inhaler sensor strap to monitor asthma inhaler use and a mobile phone application to remind and incentivize patients to use their medication. This study will assess the feasibility and acceptability of this intervention to patients.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable asthma

Timeline
Completed

Started Jan 2014

Shorter than P25 for not_applicable asthma

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2014

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2014

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

April 7, 2015

Completed
20 days until next milestone

First Posted

Study publicly available on registry

April 27, 2015

Completed
Last Updated

April 27, 2015

Status Verified

April 1, 2015

Enrollment Period

5 months

First QC Date

April 7, 2015

Last Update Submit

April 24, 2015

Conditions

Keywords

Patient ComplianceMobile ApplicationsMedication Adherence

Outcome Measures

Primary Outcomes (1)

  • Evidence of ability to monitor medication use at home via a sensor strap

    Ability to measure medication use via the sensor strap and upload that information to the HIPAA (Health Insurance Portability and Accountability Act) compliant server.

    12 weeks

Secondary Outcomes (2)

  • Patient feedback for improved design of a mobile adherence tool

    12 weeks

  • Acceptability of mobile adherence strategy for adolescents with asthma (Based on questions as part of baseline/followup visits and focus group.)

    12 weeks

Study Arms (3)

Control

NO INTERVENTION

Patients in this arm were given no intervention. Their self-reported medication adherence was assessed at the baseline (week 0) and follow-up (week 12) visits but during the study period they did not receive any intervention.

Medication Sensor Only

SHAM COMPARATOR

These patients received the medication use sensor (sham intervention) and downloaded a sham version of the mobile app. Thus, the medication use from these patients was able to be recorded but the patients did not receive reminders or incentives or the ability to see their medication use via the real mobile app. Intervention: inhaler sensor

Device: Inhaler sensor

Medication Sensor and Mobile App

EXPERIMENTAL

These patients received the medication use sensor and the mobile app with reminders (intervention arm). Interventions: inhaler sensor and mobile application for asthma adherence

Device: Inhaler sensorBehavioral: Mobile application for asthma adherence

Interventions

Inhaler sensor strap that tracks inhaler use via a pressure sensitive switch.

Medication Sensor OnlyMedication Sensor and Mobile App

Mobile phone application that sends reminders, allows patients to see their medication use, and provides points and other incentives for medication use.

Medication Sensor and Mobile App

Eligibility Criteria

Age11 Years - 19 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Age 11-19
  • Asthma diagnosis
  • Currently on a daily controller medication for Asthma
  • English-speaking

You may not qualify if:

  • Pregnant
  • Foster Care
  • Emancipated minor

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (9)

  • Stern L, Berman J, Lumry W, Katz L, Wang L, Rosenblatt L, Doyle JJ. Medication compliance and disease exacerbation in patients with asthma: a retrospective study of managed care data. Ann Allergy Asthma Immunol. 2006 Sep;97(3):402-8. doi: 10.1016/S1081-1206(10)60808-3.

    PMID: 17042149BACKGROUND
  • Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001 Aug;23(8):1296-310. doi: 10.1016/s0149-2918(01)80109-0.

    PMID: 11558866BACKGROUND
  • Chapman KR, Walker L, Cluley S, Fabbri L. Improving patient compliance with asthma therapy. Respir Med. 2000 Jan;94(1):2-9. doi: 10.1053/rmed.1999.0667.

    PMID: 10714473BACKGROUND
  • Einarson TR. Drug-related hospital admissions. Ann Pharmacother. 1993 Jul-Aug;27(7-8):832-40. doi: 10.1177/106002809302700702.

    PMID: 8364259BACKGROUND
  • Bender BG, Rand C. Medication non-adherence and asthma treatment cost. Curr Opin Allergy Clin Immunol. 2004 Jun;4(3):191-5. doi: 10.1097/00130832-200406000-00009.

    PMID: 15126940BACKGROUND
  • Lasmar L, Camargos P, Champs NS, Fonseca MT, Fontes MJ, Ibiapina C, Alvim C, Moura JA. Adherence rate to inhaled corticosteroids and their impact on asthma control. Allergy. 2009 May;64(5):784-9. doi: 10.1111/j.1398-9995.2008.01877.x. Epub 2009 Jan 21.

    PMID: 19183166BACKGROUND
  • Patrick H, Williams GC. Self-determination theory: its application to health behavior and complementarity with motivational interviewing. Int J Behav Nutr Phys Act. 2012 Mar 2;9:18. doi: 10.1186/1479-5868-9-18.

    PMID: 22385676BACKGROUND
  • McCallum S. Gamification and serious games for personalized health. Stud Health Technol Inform. 2012;177:85-96.

    PMID: 22942036BACKGROUND
  • Csikszentmihalyi M, Rathunde K. The measurement of flow in everyday life: toward a theory of emergent motivation. Nebr Symp Motiv. 1992;40:57-97. No abstract available.

    PMID: 1340523BACKGROUND

MeSH Terms

Conditions

AsthmaPatient ComplianceMedication Adherence

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System DiseasesPatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Michael M Parides, PhD

    Icahn School of Medicine at Mount Sinai

    PRINCIPAL INVESTIGATOR
  • Andrew M Ting, MD

    Icahn School of Medicine at Mount Sinai

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 7, 2015

First Posted

April 27, 2015

Study Start

January 1, 2014

Primary Completion

June 1, 2014

Study Completion

June 1, 2014

Last Updated

April 27, 2015

Record last verified: 2015-04